Pliant Therapeutics CBO Hans Hull resigns effective October 20, 2025

PLIANT THERAPEUTICS, INC.

Hans Hull resigned as Chief Business Officer, effective October 20, 2025.
Resignation was not due to any disagreement on operations, policies, or practices.
No replacement has been announced as of the filing date.

item 5.02

PLIANT THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001746473-25-000159

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.